New insights into glucagon-like peptide-1 receptor agonist treatment considerations.

26 August 2018 (13:10 - 13:25)

Organised by:

Video

Slides

Sign in to view the resources

About the speaker

Professor Subodh Verma

St. Michael's Hospital, Toronto (Canada)

3 More presentations in this session

Presentation thumbnail

Glucagon-like peptide-1 receptor agonists and changing paradigms in clinical practice.

Doctor B. Scirica (Boston, US)

Presentation thumbnail

Clinical aspects: type 2 diabetes, cardiovascular disease and glucagon-like peptide-1 receptor agonists.

Professor M. Pfeffer (Boston, US)

Presentation thumbnail

Perspective on glucagon-like peptide-1 receptor agonists in type 2 diabetes and cardiovascular disease: Interactive discussion.

Doctor B. Scirica (Boston, US) Professor M. Pfeffer (Boston, US) Professor S. Verma (Toronto, CA)

Access the full session

Session thumbnail

Discussion: Glucagon-like peptide-1 receptor agonists and changing paradigms in clinical practice

The Event

ESC Congress 2018

26 August 2018 13:10 CET

You may be interested in

Congress Presentation

Effect of oral semaglutide on CV outcomes across the vascular disease spectrum, from no vascular disease to polyvascular disease, in high-risk type 2 diabetes

1 September 2025

Congress Presentation

Substrate modulation and metabolic therapies

25 April 2026

Congress Presentation

Hemodynamic Changes in response to GLP-1 RA treatment in ICD and CRT patients: Insights from HeartLogic Sensor Data

1 September 2025

Congress Presentation

Adherence and discontinuation of sglt2-inhibitors and glp1-r agonists in patients with type 2 diabetes with and without cardiovascular disease

27 August 2022

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources